<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Considerable disagreement exists regarding the levels of immunoreactive <z:chebi fb="105" ids="17234">glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> in patients with Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> levels were therefore studied during oral <z:chebi fb="105" ids="17234">glucose</z:chebi> and mixed meal tolerance tests in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (n = 31) and newly presenting previously untreated patients with Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (n = 68) </plain></SENT>
<SENT sid="2" pm="."><plain>The tests were performed in random order after overnight fasts and blood samples were taken at 30 min intervals for 4 h </plain></SENT>
<SENT sid="3" pm="."><plain>During the oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> levels increased in the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects from a fasting value of 20 +/- 3 pmol/l to a peak of 68 +/- 5 pmol/l at 30 min and in the Type 2 diabetic patients from a similar fasting level of 27 +/- 3 pmol/l to a higher peak value of 104 +/- 6 pmol/l at 30 min (p less than 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> levels were significantly higher in the diabetic patients compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects from 30-90 min (p less than 0.01-0.001) following oral <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>During the meal tolerance test <z:chebi fb="105" ids="17234">glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> levels increased in the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects from a pre-prandial value of 22 +/- 4 pmol/l to a peak of 93 +/- 6 pmol/l at 90 min and in the Type 2 diabetic patients from a similar basal level of 25 +/- 2 pmol/l to a higher peak of 133 +/- 7 pmol/l at 60 min </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> concentrations were significantly higher in Type 2 diabetic patients compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects at 30 min (p less than 0.001), 60 min (p less than 0.01) and from 210-240 min (p less than 0.05) during the meal tolerance test </plain></SENT>
<SENT sid="7" pm="."><plain>The groups were subdivided on the basis of degree of <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:chebi fb="105" ids="17234">glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> concentrations were still higher in the diabetic subgroups compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects matched for weight </plain></SENT>
<SENT sid="8" pm="."><plain>Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> is associated with an exaggerated <z:chebi fb="105" ids="17234">glucose</z:chebi> dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> response to oral <z:chebi fb="105" ids="17234">glucose</z:chebi> and mixed meals which is independent of any effect of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>